GERON CORP Depreciation
GERON CORP (GERN) reported Depreciation of $101.00 thousand for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2021-08-16
- GERON CORP depreciation for the quarter ending 2021-06-30 was $53.00K, a 60.61% increase year-over-year.
- GERON CORP depreciation for the quarter ending 2021-03-31 was $48.00K, a 77.78% increase year-over-year.
- GERON CORP depreciation for the quarter ending 2020-12-31 was $49.00K, a 68.97% increase year-over-year.
- GERON CORP depreciation for the quarter ending 2020-09-30 was $49.00K, a 444.44% increase year-over-year.
- GERON CORP depreciation for fiscal 2020 was $158.00K, a 146.88% increase from fiscal 2019.
- GERON CORP depreciation for fiscal 2019 was $64.00K, a 8.47% increase from fiscal 2018.
- GERON CORP depreciation for fiscal 2018 was $59.00K, a 22.37% decline from fiscal 2017.
- GERON CORP depreciation for fiscal 2017 was $76.00K, a 6.17% decline from fiscal 2016.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2021-06-30 | $53.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $101.00K 10-Q · filed 2021-08-16 | $150.00K derived: sum of 3 quarters · filed 2021-08-16 | $199.00K derived: sum of 4 quarters · filed 2021-08-16 |
| 2021-03-31 | $48.00K 10-Q · filed 2021-05-10 | $97.00K derived: sum of 2 quarters · filed 2021-05-10 | $146.00K derived: sum of 3 quarters · filed 2021-05-10 | $179.00K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-12-31 | $49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $98.00K derived: sum of 2 quarters · filed 2021-03-11 | $131.00K derived: sum of 3 quarters · filed 2021-08-16 | $158.00K 10-K · filed 2021-03-11 |
| 2020-09-30 | $49.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $82.00K derived: sum of 2 quarters · filed 2021-08-16 | $109.00K 10-Q · filed 2020-11-05 | $138.00K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-06-30 | $33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $60.00K 10-Q · filed 2021-08-16 | $89.00K derived: sum of 3 quarters · filed 2021-08-16 | $98.00K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $27.00K 10-Q · filed 2021-05-10 | $56.00K derived: sum of 2 quarters · filed 2021-05-10 | $65.00K derived: sum of 3 quarters · filed 2021-05-10 | $76.00K derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $38.00K derived: sum of 2 quarters · filed 2021-03-11 | $49.00K derived: sum of 3 quarters · filed 2021-03-11 | $64.00K 10-K · filed 2021-03-11 |
| 2019-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $20.00K derived: sum of 2 quarters · filed 2020-11-05 | $35.00K 10-Q · filed 2020-11-05 | $49.00K derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $26.00K 10-Q · filed 2020-08-06 | $40.00K derived: sum of 3 quarters · filed 2021-03-11 | $54.00K derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-03-31 | $15.00K 10-Q · filed 2020-05-28 | $29.00K derived: sum of 2 quarters · filed 2021-03-11 | $43.00K derived: sum of 3 quarters · filed 2021-03-11 | $58.00K derived: sum of 4 quarters · filed 2021-03-11 |
| 2018-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $28.00K derived: sum of 2 quarters · filed 2021-03-11 | $43.00K derived: sum of 3 quarters · filed 2021-03-11 | $59.00K 10-K · filed 2021-03-11 |
| 2018-09-30 | $14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $29.00K derived: sum of 2 quarters · filed 2019-11-06 | $45.00K 10-Q · filed 2019-11-06 | $64.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $31.00K 10-Q · filed 2019-08-01 | $50.00K derived: sum of 3 quarters · filed 2020-03-12 | $69.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $16.00K 10-Q · filed 2019-05-02 | $35.00K derived: sum of 2 quarters · filed 2020-03-12 | $54.00K derived: sum of 3 quarters · filed 2020-03-12 | $72.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $38.00K derived: sum of 2 quarters · filed 2020-03-12 | $56.00K derived: sum of 3 quarters · filed 2020-03-12 | $76.00K 10-K · filed 2020-03-12 |
| 2017-09-30 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $37.00K derived: sum of 2 quarters · filed 2018-11-01 | $57.00K 10-Q · filed 2018-11-01 | |
| 2017-06-30 | $18.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | $38.00K 10-Q · filed 2018-07-31 | ||
| 2017-03-31 | $20.00K 10-Q · filed 2018-05-10 | |||
| 2016-12-31 | $81.00K 10-K · filed 2019-03-07 | |||
| 2015-12-31 | $56.00K 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |